Biopharma has a brand new target: Cancer-specific collagen
MedCity News
JULY 22, 2022
Researchers at the University of Texas MD Anderson Cancer Center published a new study revealing that cancer cells make their own unique form of collagen to help them grown and proliferate. This means drug developers may have a new, highly specific target for oncology therapeutics.
Let's personalize your content